GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gelstat GSAC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Gelstat annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 31 Dec 2008, filed on 22 Oct 2012.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$267,962$349,730$149,527$2,333$7,022
Operating income−$241,853−$281,000−$165,827−$602,000−$313,000
Net income−$326,575−$373,000−$210,111−$761,000−$475,000
Free cash flow−$62,807−$57,170−$106,290−$172,380−$204,858
Total assets$269,576$170,888$185,879$18,830$182,090
Shareholders' equity−$1.3m−$1.0m−$778,492−$705,255−$328,968

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.